Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants

Yoder, Bradley A.; Van Meurs, Krisa P; Walker, M. Whit; Hasan, Shabih U.; Potenziano, Jim; Konduri, Girija G; Perez, José A. Angel

doi:10.1001/jamapediatrics.2017.2618

Record: found
Abstract: not found
Article: not found

Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants : A Randomized Clinical Trial

Author(s): Shabih U. Hasan , Jim Potenziano , Girija G. Konduri , Jose A. Perez , Krisa P. Van Meurs , M. Whit Walker , Bradley A. Yoder ¹

Publication date Created: November 01 2017

Publication date (Print): November 01 2017

Journal: JAMA Pediatrics

Publisher: American Medical Association (AMA)

Read this article at

ScienceOpenPublisher PMC

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Bronchopulmonary dysplasia (BPD) occurs in approximately 40% of infants born at younger than 30 weeks' gestation and is associated with adverse pulmonary and neurodevelopmental outcomes.

Related collections

Author and article information

Journal

Title: JAMA Pediatrics

Abbreviated Title: JAMA Pediatr

Publisher: American Medical Association (AMA)

ISSN (Print): 2168-6203

Publication date Created: November 01 2017

Publication date (Print): November 01 2017

Volume: 171

Issue: 11

Page: 1081

Affiliations

[1 ]for the Newborns Treated With Nitric Oxide (NEWNO) Trial Group

Article

DOI: 10.1001/jamapediatrics.2017.2618

PMC ID: 5710365

PubMed ID: 28973344

SO-VID: 5bc73ec4-3849-4fc7-939b-7398a1bf1184

History

Data availability:

Comments

Comment on this article

scite_

Cited by 17

See all cited by

- Version 1
- Version 1